Authors:
Hall, IH
Barnes, BJ
Ward, ES
Wheaton, JR
Warren, AE
Izydore, RA
Citation: Ih. Hall et al., Tmolt(4) leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones, ARCH PHARM, 334(4), 2001, pp. 109-116
Citation: Bj. Barnes et al., Analysis of the in vitro inhibition of murine and human tumor cell growth by pyrazole derivatives and a substituted azabicyclo[3.1.0] hexane-2,4-dione, ANTICANC R, 21(4A), 2001, pp. 2313-2321
Citation: Bj. Barnes et al., Cytotoxicity and mode of action of 1-(1-cyclohexenyl) and 1-unsubstituted 3,5-pyrazolidinediones in human molt(4) T cell leukemia, ANTICANC R, 21(3B), 2001, pp. 1857-1868
Authors:
Izydore, RA
Zhang, Y
Zhou, XM
Warren, AE
Wheaton, JR
Hall, IH
Citation: Ra. Izydore et al., The cytotoxicity of 1-(1-phenylalkylideneamino)-2,4-azetidinediones and their mode of action in human and murine tumor cells, ANTICANC R, 21(1A), 2001, pp. 157-165
Authors:
Hall, IH
Covington, DW
Wheaton, JR
Izydore, RA
Zhou, XM
Citation: Ih. Hall et al., Cytotoxicity of 2-ethenyl-2,3-dihydrophthalazine-1,4-diones in murine and human tumor cultured cells, PHARMAZIE, 56(2), 2001, pp. 168-174
Authors:
Hall, IH
Barnes, BJ
Ward, ES
Wheaton, JR
Izydore, RA
Citation: Ih. Hall et al., Specific inhibition of Type II inosine monophosphate dehydrogenase activity of Tmolt(4) T cell human leukaemia cells by 3-methoxy and di-benzohydroxamic acids, maleic hydrazide and malonic acids, J PHARM PHA, 53(5), 2001, pp. 749-755
Authors:
Barnes, BJ
Izydore, RA
Eakin, AE
Hall, IH
Citation: Bj. Barnes et al., Induction of Tmolt(4) leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: Specificity for type II inosine 5 '-monophosphate dehydrogenase, J PHARM EXP, 298(2), 2001, pp. 790-796
Authors:
Barnes, BJ
Izydore, RA
Eakin, AE
Hall, IH
Citation: Bj. Barnes et al., Mechanism of action of the antitumor agents 6-benzoyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: Potent inhibitors of human type II inosine 5 '-monophosphate dehydrogenase, INT J CANC, 94(2), 2001, pp. 275-281
Authors:
Barnes, BJ
Eakin, AE
Izydore, RA
Hall, IH
Citation: Bj. Barnes et al., Implications of selective type IIIMP dehydrogenase (IMPDH) inhibition by the 6-ethoxycarbonyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones on tumor cell death, BIOCH PHARM, 62(1), 2001, pp. 91-100
Authors:
Barnes, BJ
Eakin, AE
Izydore, RA
Hall, IH
Citation: Bj. Barnes et al., Selective inhibition of human molt-4 leukemia type II inosine 5 '-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones, BIOCHEM, 39(45), 2000, pp. 13641-13650
Citation: C. Maclauchlin et al., Synthesis and cytotoxic action of 1-oxoalkyl and 1,2-dioxoalkyl-1,2,4-triazolidine-3,5-diones in murine and human tissue cultured cells, ARCH PHARM, 332(7), 1999, pp. 225-232
Authors:
Hall, IH
Izydore, RA
Warren, AE
Barnes, CR
Citation: Ih. Hall et al., Cytotoxicity and mode of action of aliphatic dicarboxylic acids in L1210 lymphocytic leukemia cells, ANTICANC R, 19(1A), 1999, pp. 205-211
Authors:
Hall, IH
Taylor, K
Izydore, RA
Daniels, DL
Citation: Ih. Hall et al., Effects of benzohydroxamic acids on L1210 lymphoid leukemia cell nucleic acid metabolism, PHARMAZIE, 53(11), 1998, pp. 794-799